Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study
Crossref DOI link: https://doi.org/10.1007/s40261-015-0349-8
Published Online: 2015-10-19
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tani, Shigemasa
Nagao, Ken
Hirayama, Atsushi
Text and Data Mining valid from 2015-10-19
